Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06554054

A Study of GZR18 Tablet in Chinese Healthy Subjects

A Randomized, Open Phase I Trial to Evaluate the Bioavailability, Pharmacokinetics, Pharmacodynamics, Safety and Tolerance of GZR18 Tablet and Evaluate the Effect of Meal Time on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerance of GZR18 Tablet in Chinese Healthy Adult Subjects

Status
Active Not Recruiting
Phase
Phase 1
Study type
Interventional
Enrollment
92 (actual)
Sponsor
Gan and Lee Pharmaceuticals, USA · Industry
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

The aim of the trial is to investigate the the bioavailability, pharmacokinetics, pharmacodynamics, safety and tolerance of single and multiple doses of GZR18 tablet in healthy subjects.

Conditions

Interventions

TypeNameDescription
DRUGGZR18Oral administered the GZR18 tablet

Timeline

Start date
2024-04-01
Primary completion
2024-12-09
Completion
2024-12-09
First posted
2024-08-14
Last updated
2024-08-14

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06554054. Inclusion in this directory is not an endorsement.